HOXA11 and nasopharyngeal carcinoma: More importantly, Lin et al. found that the expression of HOXA11-AS was up-regulated in nasopharyngeal carcinoma drug-resistant cells, and the silencing of HOXA11-AS reversed the drug resistance of nasopharyngeal carcinoma to cisplatin [46].